Small Businesses in Non-addictive Analgesic Therapeutics Development: HEAL Initiative Webinar on funding opportunities beyond SBIR/STTR

This webinar is for Small Businesses to learn about additional funding mechanisms beyond SBIR to support the discovery and pre-clinical development of non-addictive pain treatments:

HEAL Initiative: Planning Studies for Initial Analgesic Development (R61 Clinical Trial Not Allowed) RFA-NS-21-029

HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development (U19, Clinical Trial Not Allowed) RFA-NS-21-015

HEAL Initiative: Non-addictive Analgesic Therapeutics [Small Molecules and Biologics] Development to Treat Pain (UG3/UH3 Clinical Trial Optional) RFA-NS-21-010

The goal of these announcements is to accelerate the optimization and development of promising small molecule and biologic hits/leads to Phase I clinical trials and readiness for the Early Phase Pain Investigation Clinical Network (EPPIC-Net) or other Phase II clinical studies.

View the Webinar Recording